Shopping Cart
- Remove All
- Your shopping cart is currently empty
Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronic Acid (ZOL 446) is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $32 | In Stock | |
25 mg | $47 | In Stock | |
50 mg | $77 | In Stock | |
100 mg | $127 | In Stock | |
200 mg | $188 | In Stock | |
500 mg | $317 | In Stock |
Description | Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronic Acid (ZOL 446) is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis. |
In vitro | Zoledronic acid (120 mg/kg, subcutaneously) prevented damage formation, prevented cancellous bone loss and loss of bone mineral density, and reduced osteoclast circumference in 5T2 mM mice, also decreasing paraprotein concentration and tumor load, and reducing angiogenesis. |
In vivo | Zoledronic acid (120 mg/kg, subcutaneously) prevented damage formation, prevented cancellous bone loss and loss of bone mineral density, and reduced osteoclast circumference in 5T2 mM mice, also decreasing paraprotein concentration and tumor load, and reducing angiogenesis. |
Alias | Zometa, Zoledronate, ZOL 446, CGP42446A, CGP 42446 |
Molecular Weight | 272.09 |
Formula | C5H10N2O7P2 |
Cas No. | 118072-93-8 |
Smiles | C(P(=O)(O)O)(P(=O)(O)O)(CN1C=CN=C1)O |
Relative Density. | 2.13 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | H2O: 1.6 mg/mL (5.88 mM), Sonication is recommended. 0.1M NAOH: 12.5 mg/mL (45.94 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
H2O/0.1M NAOH
0.1M NAOH
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.